MX9200948A - Composicion farmaceutica para el tratamiento de isquemia cerebral en mamiferos. - Google Patents

Composicion farmaceutica para el tratamiento de isquemia cerebral en mamiferos.

Info

Publication number: MX9200948A
Authority: MX; Mexico
Prior art keywords: mammals; treatment; pharmaceutical composition; brain ischemia; ischemia
Prior art date: 1991-03-05

Application number

MX9200948A

Other languages

English (en)

Inventor

Giuseppe Giardina

Geoffrey Douglas Clarke

Original Assignee

Lo Zambeletti S P A

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-03-05

Filing date

1992-03-04

Publication date

1992-11-01

1992-03-04 Application filed by Lo Zambeletti S P A filed Critical Lo Zambeletti S P A

1992-11-01 Publication of MX9200948A publication Critical patent/MX9200948A/es

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

MX9200948A 1991-03-05 1992-03-04 Composicion farmaceutica para el tratamiento de isquemia cerebral en mamiferos. MX9200948A (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB919104656A GB9104656D0 (en)	1991-03-05	1991-03-05	Pharmaceuticals

Publications (1)

Publication Number	Publication Date
MX9200948A true MX9200948A (es)	1992-11-01

Family

ID=10691041

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MX9200948A MX9200948A (es)	1991-03-05	1992-03-04	Composicion farmaceutica para el tratamiento de isquemia cerebral en mamiferos.

Country Status (8)

Country	Link
EP (1)	EP0574477A1 (es)
CA (1)	CA2105589A1 (es)
GB (1)	GB9104656D0 (es)
IE (1)	IE920679A1 (es)
MX (1)	MX9200948A (es)
PT (1)	PT100188A (es)
WO (1)	WO1992015304A2 (es)
ZA (1)	ZA921575B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8926560D0 (en) *	1989-11-24	1990-01-17	Zambeletti Spa L	Pharmaceuticals
US5428042A (en) *	1990-04-28	1995-06-27	Dr Lo Zambeletti S.P.A.	1-(2H-1-oxo-3,4-dihydronaphtyl-6-yl)-acetyl-piperidines as kappa agonists
DE602005022572D1 (de)	2004-03-12	2010-09-09	Lilly Co Eli	Antagonisten des opioidrezeptors
US7615556B2 (en)	2006-01-27	2009-11-10	Bristol-Myers Squibb Company	Piperazinyl derivatives as modulators of chemokine receptor activity
US7601844B2 (en)	2006-01-27	2009-10-13	Bristol-Myers Squibb Company	Piperidinyl derivatives as modulators of chemokine receptor activity
TWI433838B (zh)	2008-06-25	2014-04-11	必治妥美雅史谷比公司	作為趨化因子受體活性調節劑之六氫吡啶衍生物
CA2812526A1 (en)	2010-05-06	2011-11-10	Vertex Pharmaceuticals Incorporated	Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels
US8642622B2 (en)	2010-06-16	2014-02-04	Bristol-Myers Squibb Company	Piperidinyl compound as a modulator of chemokine receptor activity
DK2670752T3 (en)	2011-02-02	2016-07-04	Vertex Pharma	PYRROLOPYRAZINE SPIROCYCLIC PIPERIDINAMIDE AS ION CHANNEL MODULATORS
WO2012112743A1 (en)	2011-02-18	2012-08-23	Vertex Pharmaceuticals Incorporated	Chroman - spirocyclic piperidine amides as modulators of ion channels
EP2686325B1 (en)	2011-03-14	2016-12-14	Vertex Pharmaceuticals Incorporated	Morpholine-spirocyclic piperidine amides as modulators of ion channels

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0330468A3 (en) *	1988-02-23	1991-04-03	Glaxo Group Limited	Use of heterocyclic derivatives as kappa-opioid receptor agonists in the treatment of cerebral ischaemia
EP0330467A1 (en) *	1988-02-23	1989-08-30	Glaxo Group Limited	Heterocyclic compounds
GB8804104D0 (en) *	1988-02-23	1988-03-23	Glaxo Group Ltd	Chemical compounds
GB8813714D0 (en) *	1988-06-09	1988-07-13	Glaxo Group Ltd	Chemical compounds
DE68924751T2 (de) *	1988-09-26	1996-04-11	Smithkline Beecham Farma	Azacyclische Verbindungen, verwendbar als Arzneimittel.

1991
- 1991-03-05 GB GB919104656A patent/GB9104656D0/en active Pending
1992
- 1992-03-02 PT PT100188A patent/PT100188A/pt not_active Application Discontinuation
- 1992-03-03 IE IE067992A patent/IE920679A1/en not_active Application Discontinuation
- 1992-03-03 ZA ZA921575A patent/ZA921575B/xx unknown
- 1992-03-04 WO PCT/EP1992/000492 patent/WO1992015304A2/en not_active Ceased
- 1992-03-04 EP EP92906079A patent/EP0574477A1/en not_active Withdrawn
- 1992-03-04 CA CA002105589A patent/CA2105589A1/en not_active Abandoned
- 1992-03-04 MX MX9200948A patent/MX9200948A/es unknown

Also Published As

Publication number	Publication date
WO1992015304A3 (en)	1993-06-24
CA2105589A1 (en)	1992-09-06
PT100188A (pt)	1993-05-31
ZA921575B (en)	1992-12-30
IE920679A1 (en)	1992-09-09
WO1992015304A2 (en)	1992-09-17
GB9104656D0 (en)	1991-04-17
EP0574477A1 (en)	1993-12-22

Similar Documents

Publication	Publication Date	Title
MX9207008A (es)	1993-06-01	Medicamentos para el tratamiento de condiciones inflamatorias o para la analgesia.
MX9200948A (es)	1992-11-01	Composicion farmaceutica para el tratamiento de isquemia cerebral en mamiferos.
AU4530989A (en)	1990-05-31	Pharmaceutical composition for the treatment of cerebral edema
MX9205637A (es)	1993-05-01	Metodo para prevenir el rechazo de aloinjertos.
MX9202507A (es)	1992-11-01	Composicion farmaceutica para el tratamiento de esofagitis de reflujo.
MX9201609A (es)	1992-10-01	Procedimiento para la hidrogenolisis de mezclas de halocarburos.
MX164619B (es)	1992-09-09	Composicion para el tratamiento de lesiones cutaneas
MX9201258A (es)	1992-10-01	Compuestos para el tratamiento del cancer y procedimiento para su preparacion.
MX9200429A (es)	1992-07-01	Procedimiento para el acortamiento del tiempo de acceso
MX9204286A (es)	1993-01-29	Agentes para el tratamiento de semillas.
BR9507732A (pt)	1997-08-19	Composição farmacêutica para o tratamento de glaucoma
IT8720034A0 (it)	1987-04-08	Composizioni farmaceutiche per il trattamento di sindromi psico-organiche cerebrali.
ES2019583B3 (es)	1991-07-01	Composicion para el tratamiento de infecciones.
FI873727A7 (fi)	1988-02-28	Terebraaliseen iskemiaaseen liittyvien häiriöiden hoitoon tarkoitettu terapeuttinen aine.
MX9202034A (es)	1992-11-01	Composicion de derivados de antibioticos de macrolida para el tratamiento o prevencion de mastitis en rumiantes.
IT8322949A0 (it)	1983-09-21	Composizione farmaceutica utile per il miglioramento e/o il trattamento di sintomi mentali provocati da disturbi organici nel cervello.
MX9204485A (es)	1993-02-01	Composicion farmaceutica para el tratamiento de enfermedades inflamatorias.
BR9405887A (pt)	1995-12-12	Medicamento para o tratamento de infecções por retrovirus
MX9200555A (es)	1992-08-01	Composicion farmaceutica para la aplicacion topicaterapeutica en el tratamiento de catarata pre-senil y senil.
MX9201665A (es)	1992-10-01	Composicion farmaceutica para el tratamiento de infecciones del virus de inmunodeficiencia humana del tipo 1 en mamiferos.
MX9201735A (es)	1992-10-01	Composicion farmaceutica para el tratamiento y profilaxis de inflamacion y dolor en mamiferos.
MX9203587A (es)	1992-07-01	Composicion farmaceutica para el tratamiento de la osteodistro fia renal.
ES1017890Y (es)	1992-07-16	Dispositivo para el tratamiento de uneros.
ES1020134Y (es)	1993-01-01	Mesa audiovisual para el juego de bingo.
ES1015773Y (es)	1992-03-01	Rail para el montaje de muebles desplazables.